FCECX | VCDAX | FCECX / VCDAX | |
Total Expense Ratio | 1.74 | 0.09 | 1,933% |
Annual Report Gross Expense Ratio | 1.74 | 0.09 | 1,933% |
Fund Existence | 28 years | 20 years | - |
Gain YTD | -0.523 | -0.118 | 442% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 489M | 6.73B | 7% |
Annual Yield % from dividends | 0.00 | 0.82 | - |
Returns for 1 year | 11.45 | 21.28 | 54% |
Returns for 3 years | 39.72 | 53.37 | 74% |
Returns for 5 years | 29.82 | 77.20 | 39% |
Returns for 10 years | 95.21 | 200.53 | 47% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
AZTD | 28.15 | 0.23 | +0.83% |
Aztlan Global Stock Sel Dm SMID ETF | |||
BKMC | 106.07 | 0.56 | +0.53% |
BNY Mellon US Mid Cap Core Equity ETF | |||
MSLC | 52.55 | 0.23 | +0.44% |
Morgan Stanley Pathway Large Cap Eq ETF | |||
SPMB | 21.90 | 0.05 | +0.23% |
SPDR® Portfolio Mortgage Backed Bond ETF | |||
XPH | 43.28 | 0.03 | +0.07% |
SPDR® S&P Pharmaceuticals ETF |